Conversion Surgery After HAIC-Based Combination Therapy with Targeted Therapy and Immune Checkpoint Inhibitors for Initially Unresectable Hepatocellular Carcinoma: A Retrospective Cohort Study
Journal of Hepatocellular Carcinoma · 2026-10 · Volume 13 · 1-13
DOI: 10.2147/jhc.s644129 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Hepatocellular Carcinoma, 2026-10. Verfasst von Xiaolong Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, 442000, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, 442000, People's Republic of China.
- Department of Hepatopancreatobiliary Surgery, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, 442000, People's Republic of China.
- Department of Outpatient, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, 442000, People's Republic of China.
ORCID-Profile: Jun Hu
Zitieren
APA
Zhang, X., Hu, J., Lan, H., Shen, X., Zhou, M., & Tian, Y. (2026). Conversion Surgery After HAIC-Based Combination Therapy with Targeted Therapy and Immune Checkpoint Inhibitors for Initially Unresectable Hepatocellular Carcinoma: A Retrospective Cohort Study. Journal of Hepatocellular Carcinoma, Volume 13, 1-13. https://doi.org/10.2147/jhc.s644129
Vancouver
Zhang X, Hu J, Lan H, Shen X, Zhou M, Tian Y. Conversion Surgery After HAIC-Based Combination Therapy with Targeted Therapy and Immune Checkpoint Inhibitors for Initially Unresectable Hepatocellular Carcinoma: A Retrospective Cohort Study. Journal of Hepatocellular Carcinoma. 2026;Volume 13:1-13. doi:10.2147/jhc.s644129
BibTeX
@article{Zhang2026,
author = {Zhang, Xiaolong and Hu, Jun and Lan, Haoming and Shen, Xianfeng and Zhou, Meng and Tian, Youyou},
title = {Conversion Surgery After HAIC-Based Combination Therapy with Targeted Therapy and Immune Checkpoint Inhibitors for Initially Unresectable Hepatocellular Carcinoma: A Retrospective Cohort Study},
journal = {Journal of Hepatocellular Carcinoma},
year = {2026},
volume = {Volume 13},
pages = {1--13},
doi = {10.2147/jhc.s644129}
}
EUVIMED